• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,808.48 544.15
( 0.71%)
Global Indices
Nasdaq
51,705.57 482.31
(0.94%)
Dow Jones
7,575.20 122.74
(1.65%)
Hang Seng
69,393.70 76.20
(0.11%)
Nikkei 225
10,435.69 -36.03
(-0.34%)
Forex
USD-INR
94.92 -0.57
(-0.60%)
EUR-INR
109.83 -0.42
(-0.38%)
GBP-INR
127.25 -0.49
(-0.38%)
JPY-INR
0.59 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Biocon Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532523
INE376G01013
167.0598066
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BIOCON
283.16
67470.29
EPS(TTM)
Face Value()
Div & Yield %
1.47
5
0.12
 

Suprajit Engineering consolidated net profit rises 161.05% in the March 2026 quarter
May 26,2026
Net profit of Suprajit Engineering rose 161.05% to Rs 71.11 crore in the quarter ended March 2026 as against Rs 27.24 crore during the previous quarter ended March 2025. Sales rose 18.82% to Rs 1041.93 crore in the quarter ended March 2026 as against Rs 876.92 crore during the previous quarter ended March 2025.

For the full year,net profit rose 84.01% to Rs 182.67 crore in the year ended March 2026 as against Rs 99.27 crore during the previous year ended March 2025. Sales rose 16.72% to Rs 3824.82 crore in the year ended March 2026 as against Rs 3276.95 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1041.93876.92 19 3824.823276.95 17
OPM %11.569.92 -10.3710.17 -
PBDT137.4982.60 66 448.91319.19 41
PBT97.2450.20 94 298.03197.36 51
NP71.1127.24 161 182.6799.27 84